ライフサイエンスコーパス: toxic epidermal necrolysis

1 ymptoms, and 7 with Stevens-Johnson syndrome/toxic epidermal necrolysis).

2 ma multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis.

3 lergy and a microRNA biomarker/mechanism for toxic epidermal necrolysis.

4 , anaphylaxis, Stevens-Johnson syndrome, and toxic epidermal necrolysis.

5 -host disease, Stevens-Johnson syndrome, and toxic epidermal necrolysis.

6 ning dermatoses Stevens-Johnson syndrome and toxic epidermal necrolysis.

7 vely progressing Stevens-Johnson syndrome or toxic epidermal necrolysis.

8 nges as sequalae to Stevens-Johnson syndrome/toxic epidermal necrolysis.

9 n treatment and Stevens-Johnson Syndrome and toxic epidermal necrolysis.

10 with suspected Stevens-Johnson syndrome and toxic epidermal necrolysis.

11 f patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

12 ma multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis), 2 months (drug eruption and

13 g 236 patients with Stevens-Johnson syndrome/toxic epidermal necrolysis, 86 with drug reaction with e

14 ric oxide mediates the epidermal necrosis in toxic epidermal necrolysis and provides a potential targ

15 Toxic epidermal necrolysis and Stevens-Johnson syndrome

16 ropose that a large burst of nitric oxide in toxic epidermal necrolysis and Stevens-Johnson syndrome

17 hich may rarely progress to life-threatening toxic epidermal necrolysis, and colitis, characterized b

18 en implicated in the pathogenesis of eczema, toxic epidermal necrolysis, and drug-induced skin erupti

19 deaths (resulting from pneumococcal sepsis, toxic epidermal necrolysis, and renal failure) occurred

20 Stevens-Johnson syndrome and toxic epidermal necrolysis are severe adverse cutaneous

21 ptoms syndrome, and Stevens-Johnson syndrome/toxic epidermal necrolysis, can be severe and result in

22 , which include Stevens-Johnson syndrome and toxic epidermal necrolysis, drug reaction with eosinophi

23 3.69), erythema multiforme (IC(025) = 1.03), toxic epidermal necrolysis (IC(025) = 0.95), Stevens-Joh

24 azepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in specific Asian populations

25 se event of either Stevens-Johnson syndrome, toxic epidermal necrolysis, or aplastic anemia.

26 tients admitted for Stevens-Johnson syndrome/toxic epidermal necrolysis over a 14-year period were in

27 ired in one of four Stevens-Johnson syndrome/toxic epidermal necrolysis patients and is associated wi

28 t identification of Stevens-Johnson syndrome/toxic epidermal necrolysis patients at higher risk of in

29 A teenage survivor of toxic epidermal necrolysis presented with faint but diff

30 Although rare, Stevens-Johnson syndrome and toxic epidermal necrolysis remain among the most devasta

31 ecrolysis, the Severity-of-Illness Score for Toxic Epidermal Necrolysis (SCORTEN), was recently found

32 d in evaluation of severity was the Score of Toxic Epidermal Necrolysis (SCORTEN), which ranges from

33 purinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) and drug reaction w

34 c forms of disease, Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug reaction w

35 Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) are part of a disea

36 Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are rare but severe

37 Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are severe cutaneou

38 observed in the Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN) group, whereas glau

39 Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) is a rare but life-

40 Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a severe hyperse

41 Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is known to cause m

42 tly involved in Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN), although a detaile

43 ns (SCARs) such as Stevens-Johnson syndrome, toxic epidermal necrolysis (SJS/TEN), and drug reaction

44 ion (SCAR), such as Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), hindering continuo

45 ortant risk for Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN), which are the most

46 lications following Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN).

47 include life-threatening conditions such as toxic epidermal necrolysis, Stevens-Johnson syndrome, an

48 A search of PubMed using the keywords toxic epidermal necrolysis, Stevens-Johnson syndrome, ph

49 In the Stevens-Johnson syndrome/toxic epidermal necrolysis subgroup, significant associa

50 *1502 and Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) among carbamazepine use

51 Toxic epidermal necrolysis (TEN) and Stevens-Johnson Syn

52 Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening di

53 Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening mu

54 Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but life-threa

55 Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but life-threa

56 Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but potentiall

57 Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe drug reactio

58 (CBZ)-induced Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) as a model to study the

59 Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) cause diffuse epidermal

60 stributed Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been infrequently

61 We report a rare case of toxic epidermal necrolysis (TEN) in a 10-year-old boy wi

62 Toxic epidermal necrolysis (TEN) is a fatal drug-induced

63 Toxic epidermal necrolysis (TEN) is a severe adverse dru

64 eyes of 200 patients with chronic ocular SJS/toxic epidermal necrolysis (TEN) were included in the st

65 Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and graft-versus-host

66 including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), could be life-threaten

67 s, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug rash with eosinop

68 PPI, such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), or drug rash with eosi

69 evere ocular Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), or SJS/TEN was perform

70 including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), varies across studies.

71 onditions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).

72 s such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).

73 Stevens-Johnson syndrome/toxic epidermal necrolysis was the most common indicatio

74 One child in the placebo group had fatal toxic epidermal necrolysis with concurrent Pseudomonas a